Summary

New report, “The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Global Market size and company share data for three diabetes care devices market categories – glucose monitoring and insulin delivery.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
- Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
- Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Companies Mentioned

F. Hoffmann-La Roche Ltd
LifeScan (Johnson & Johnson)
Bayer Healthcare
Abbott Laboratories
Becton, Dickinson and Company
Medtronic
Novo Nordisk

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1207/The-Future-of-the-Diabetes-Care-Devices-Market-to-2016-The-Key-Demand-Drivers-Remain-Intact.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

The latest research, “Big Pharma’s Key Lifecycle Management Strategies: Maximizing the Market Potential” provides key data, information and analysis on the key lifecycle management strategies implemented by pharmaceutical companies. This pharmaceutical and healthcare report provides information on the Lifestyle Management Strategies (LCM) market, the reasons why companies implement LCM strategies and the challenges faced by them. This report provides comprehensive analysis of five key LCM strategies (new indications, formulation variants, extended/controlled released versions, Rx-to-OTC switch and store brand generic) using case studies. The report also provides the sales growth patterns of key drugs for which LCM activities are being carried out. It also reviews the factors determining the success and failure of the strategies providing an understanding of how to ensure success for LCM.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes :

- Analysis and data on LCM activities of top twenty pharmaceutical companies including Roche, Bayer, GSK, and Pfizer in terms of the LCM pipeline.
- Insight into the LCM activities in the top five therapeutic areas including cancer, central nervous system (CNS), cardiovascular system (CVS), metabolic diseases and infectious diseases.
- Detailed case studies for each of the key LCM strategies identified. Sales and growth trend data for selected examples for each of the key strategies.
- Sales growth analysis of top ten drugs under LCM and the timeline of LCM events
- Qualitative analysis of market drivers, restraints, future outlook and challenges faced by the LCM strategies of the companies
- Framework for measuring LCM performance and effective team structures for integrating the LCM team into the organization

Reasons to buy

The report will enhance your decision making capability. It will allow you to :

- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1481/Big-Pharma-s-Key-Lifecycle-Management-Strategies-Maximizing-the-Market-Potential.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of Ophthalmic Devices, Market Forecasts and Growth Opportunities to 2016 – The Vision Care Segment Emerges as a Key Revenue Generator” provides key data, information and analysis on the global ophthalmic devices market. The report provides market landscape, competitive landscape and market trends information on four ophthalmic devices market categories – cataract surgery devices, refractive surgery devices, vision care, and ophthalmic diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for four ophthalmic devices market categories – cataract surgery devices, refractive surgery devices, vision care, and ophthalmic diagnostic equipment.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the ophthalmic devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Essilor, Johnson & Johnson Vision Care, HOYA, CIBA Vision, Bausch & Lomb, Carl Zeiss, Alcon, Cooper Vision, and Abbott Medical Optics (AMO).

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the ophthalmic devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the ophthalmic devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global ophthalmic devices market and the factors shaping it.

Companies Mentioned

Essilor International
Johnson & Johnson Vision Care
CIBA Vision Corporation
Bausch & Lomb
Carl Zeiss
Alcon
Abbott Medical Optics
Hoya Corporation

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2145/The-Future-of-Ophthalmic-Devices-Market-Forecasts-and-Growth-Opportunities-to-2016-The-Vision-Care-Segment-Emerges-as-a-Key-Revenue-Generator.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Coal has always been the principal energy in China. Considering the slim possibility that the industries like steel and cement show the fundamental reversion in a short period, so it is difficult for coal industry to perform in the first half and even the full year 2009 as the same prosperity in 2008.

In 2008, the coal demand amounted to 2.67 billion tons in China, and 1.46 billion tons of which was consumed by electric power industry, 453 million tons in steel metallurgy, 340 million tons in building materials, and 140 million tons in chemical industry, accounting for 86.89% of China’s total coal demand.

China’s raw coal output was 2.716 billion tons in 2008, up 7.65% year-on-year, among which, the raw coal produced in county coal mines reached 994 million tons, rising 3.65% year-on-year, and accounting for 36.6% in the total, down 1.5 percentage points year-on-year. The growth in coal output in 2008 was mainly contributed to the output increase of state-owned key coal mines (up 11% year-on-year) and state-owned local coal mines (rising 6.4% year-on-year).

Firstly, the report introduces China’s coal industry development, and then it analyzes coal market layout from two aspects, demand and supply. Lastly, it gives a full picture of 22 key coal companies, including their operation and operating revenue, project investment, main business structure, latest trend and future trend.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/961/Chinas-Coal-Industry-and-Key-Companies-2008.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com